Picard Medical announced a $5 million offering of common stock and warrants priced at $0.30 per share to institutional investors. The proceeds will be used for working capital and to pay off senior secured notes and loans. The offering includes new warrants with exercise prices of $0.35, exercisable immediately, and expiring in 2 to 5 years. This financing move supports Picard Medical's ongoing operations and growth as the maker of the FDA-approved SynCardia Total Artificial Heart.
Firefly Aerospace stock surged 24% following SpaceX's successful test flight of its upgraded Starship V3 rocket and the company's IPO filing seeking up to $75 billion. The test demonstrated key advancements in rocket reusability and fueled investor e...
KNDS N.V., based in Amsterdam, has decreased its voting rights in RENK Group AG from 15.83% to 10.03% as of May 19, 2026. This change was officially reported under German securities law, reflecting a significant reduction in KNDS's influence over REN...
KNDS N.V., based in Amsterdam, has decreased its voting rights in Renk Group AG from 15.83% to 10.03% as of May 19, 2026. This change was officially reported under the German Securities Trading Act. The reduction in stake may influence shareholder dy...
FCCE, the majority shareholder of Installux, has agreed to acquire 6.38% of Installux shares from Amiral Gestion at €500 per share, totaling €8.93 million. Following this acquisition, FCCE will hold 87.45% of Installux's capital and voting rights. FC...
Moment Factory and Mitsui Fudosan have formed a long-term strategic partnership to develop large-scale immersive fan experiences, including a new Pokémon attraction set to launch in Europe in spring 2027. This collaboration combines Moment Factory's ...
